A Benefit Risk Review of Pediatric Use of Hydrocodone/Chlorpheniramine, a Prescription Opioid Antitussive Agent for the Treatment of Cough

A Benefit Risk Review of Pediatric Use of Hydrocodone/Chlorpheniramine, a Prescription Opioid Antitussive Agent for the Treatment of Cough

Hydrocodone/chlorpheniramine is a prescription opioid licensed in the USA for the relief of cough and upper respiratory symptoms associated with allergy or cold in adults, previously contraindicated in children aged 

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drugs - real world outcomes 2019-06, Vol.6 (2), p.47-57
Hauptverfasser: Sloan, Victor S., Jones, Alphia, Maduka, Chidi, Bentz, Jürgen W. G.
Format: Artikel
Sprache:eng
Schlagworte:
Age
Analgesics
Anesthesia
Antibiotics
Birth defects
Clinical medicine
Clinical trials
Drug dosages
Fatalities
Histamine
Industrial safety
Internal Medicine
Labeling
Literature reviews
Medical personnel
Medicine
Medicine & Public Health
Narcotics
Patient safety
Pediatrics
Pharmacology/Toxicology
Pharmacotherapy
Pharmacovigilance
Prescription drugs
Public health
Research methodology
Review
Review Article
Substance abuse treatment
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Hydrocodone/chlorpheniramine is a prescription opioid licensed in the USA for the relief of cough and upper respiratory symptoms associated with allergy or cold in adults, previously contraindicated in children aged 
ISSN:2199-1154
2198-9788
DOI:10.1007/s40801-019-0152-6